Form 4 for USPH U S PHYSICAL THERAPY INC /NV
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-08 · accession 0001209191-22-045144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-10 | 2022-08-08 | USPH | REEVE GRAHAM D. | COO | S - Sale | $92.24 | -3,818 | 16.2K | -19% | -$352.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-08 | S | D | 3,818 | $92.24 | 16,191 | D | — | — | (F1) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.12 to $92.50 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. (F2) Includes 16,191 shares which restrictions lapse as to 2,057 shares on October 1, 2022; 2,072 shares on January 1, 2023; 1,412 shares on each of April 1, July 1, and October 1, 2023; 1,418 shares on January 1, 2024; and 974 shares on each of April 1, July 1, and October 1, 2024; 974 shares on January 1, 2025; and 624 shares on April 1, July 1, October 1, 2025 with the final 640 shares lapsing on January 1, 2026 if he is still employed by the Company on those dates. |